Google Chrome
Safari
Firefox
Edge
Search
Patent / Nov 13, 2008
Methods and intermediates for synthesis of selective dpp-iv inhibitors
WO2008109681A3
Article / Feb 15, 2024
Drug Design Strategies, Modes of Action, Synthesis and Industrial Challenges Behind Trifluoromethylated New Chemical Entities
Journal of Biomedical Research & Environmental Sciences, 15 February 2024
Article / Apr 20, 2024
High-dose delivery platform for crystaline DPIs
OnDrugDelivery, 23 April 2024
News / May 09, 2024
Hovione and iBET announce the creation of ViSync Technologies, an innovative new company that will develop solutions for unmet needs in cell and gene therapy
News release, 09 May 2024
News / May 21, 2024
Hovione again ranks among best employers in Portugal
Hovione has placed fourth among the best companies to work in Portugal and was again the best in the Health Sector according to Randstad´s Employer Brand Research.
Article / Jun 01, 2024
Amorphous solid dispersions for nasal delivery - Powder formulation and particle engineering considerations
Inhalation Magazine, June 2024
News / May 23, 2024
Diane Villax receives achievement award at Deloitte´s Investor Relations and Governance Awards (IRGAwards) 2024
36th edition of the Investor Relations & Governance Awards (IRGAwards) promoted by Deloitte